Copyright
©The Author(s) 2020.
World J Clin Cases. Aug 6, 2020; 8(15): 3218-3229
Published online Aug 6, 2020. doi: 10.12998/wjcc.v8.i15.3218
Published online Aug 6, 2020. doi: 10.12998/wjcc.v8.i15.3218
Figure 2 Endoscopic pictures of gastric antral vascular ectasia before and after treatment with thalidomide.
A: Gastric antral vascular ectasia (GAVE) with visible bleeding prior to initiation of thalidomide; B: GAVE 3 mo after initiation of thalidomide; C: GAVE 8 mo after initiation of thalidomide.
- Citation: Bayudan AM, Chen CH. Thalidomide for refractory gastrointestinal bleeding from vascular malformations in patients with significant comorbidities. World J Clin Cases 2020; 8(15): 3218-3229
- URL: https://www.wjgnet.com/2307-8960/full/v8/i15/3218.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v8.i15.3218